New scheduling proposal
August 7, 2015
The Therapeutic Goods
Administration is seeking comments
on proposals to change the
scheduling of bismuth oxychloride
and piracetam, as well as to include
naproxen and pantoprazole in
Appendix H.
The proposed amendments
referred by the delegate for
scheduling advice for consideration
by the Advisory Committee on
Medicines Scheduling also include
an application to amend the
Schedule 2 paracetamol entry
to include paracetamol when combined with ibuprofen in pack
sizes of 12 dosage units or less.
The naproxen and pantoprazole
changes would allow advertising
of the medications to consumers,
while the bismuth oxychloride
application is to exempt the
item from schedule 4 for human
therapeutic topical use.
Submissions on the proposals
are now being sought, with a
deadline of Thu 03 Sep 2015, with
stakeholders asked for suggested
improvements, whether or not
they support the amendments,
and an assessment of how the
proposed changes might impact on
respondents.
For more details see tga.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 07 Aug 15To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Aug 15
